Bicycle Therapeutics Plc (BCYC)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 14, 2025

$12.55

P/E Ratio

N/A

Market Cap

$866.15M

Description
Add to research

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Metrics
Add to research

Overview

  • HQCambridge, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerBCYC
  • Price$12.55+0.48%

Trading Information

  • Market cap$866.15M
  • Float88.73%
  • Average Daily Volume (1m)292,709
  • Average Daily Volume (3m)541,158
  • EPS-$3.30

Company

  • Revenue$36.97M
  • Rev growth (1yr)-49.19%
  • Net income-$51.32M
  • Gross margin18.83%
  • EBITDA margin-2,612.00%
  • EBITDA-$70.61M
  • EV$681.44M
  • EV/Revenue18.43
  • P/EN/A
  • P/S23.42
  • P/B1.04
  • Debt/Equity1.33
Documents
Add to research